Sotera Health Financials

Sotera Health Co

SHCNASDAQ

Trade with Public

$19.02

0.130.69%

At close: Aug 13, 5:00 PM EST

$19.02

N/A

After Hours: 4:00 PM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, before the market open

Conference Call: The most recent conference call started at 9:00 AM, 7 days ago

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Sotera Health Financials

Sotera Health (SHC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Sotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M Estimate

Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.24 by 8.33 percent. This is a 30 percent increase over earnings of $0.20 per share from the same

Benzinga Newsdesk

PRO
Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B Est

Sotera Health (NASDAQ:SHC) raises FY2026 Adj EPS guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 analyst estimate. Raises FY2026 sales outlook from $1.233 billion-$1.251 billion to $1.236 billion-$1.254 billion vs

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Sotera Health Affirms FY2026 Adj EPS Guidance of $0.93-$1.01 vs $0.96 Est; Affirms FY2026 Sales Guidance of $1.233B-$1.251B vs $1.239B Est

Sotera Health (NASDAQ:SHC) affirms FY2026 Adj EPS guidance from $0.93-$1.01 to $0.93-$1.01 vs $0.96 analyst estimate. Affirms FY2026 sales outlook from $1.233 billion-$1.251 billion to $1.233 billion-$1.251 billion vs

Benzinga Newsdesk

PRO
Sotera Health Q1 Adj. EPS $0.18 Beats $0.17 Estimate, Sales $280.045M Beat $270.774M Estimate

Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.17 by 0 percent. This is a 28.57 percent increase over earnings of $0.14 per share from the same

Benzinga Newsdesk

PRO
Sotera Health Sees FY2026 Adj EPS $0.93-$1.01 vs $0.94 Est; Sees Sales $1.233B-$1.251B vs $1.228B Est

Full-Year 2026 OutlookNet revenues in the range of $1.233 billion to $1.251 billion, representing constant currency growth of 5.0% to 6.5% and an estimated 100bps foreign currency benefitAdjusted EBITDA in the range of

Benzinga Newsdesk

Benzinga

Benzinga

Sotera Health Co

Sotera Health Financials

Earnings & Guidance News

PROSotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M Estimate

PROSotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B Est

Earnings Scheduled For May 5, 2026

PROSotera Health Affirms FY2026 Adj EPS Guidance of $0.93-$1.01 vs $0.96 Est; Affirms FY2026 Sales Guidance of $1.233B-$1.251B vs $1.239B Est

PROSotera Health Q1 Adj. EPS $0.18 Beats $0.17 Estimate, Sales $280.045M Beat $270.774M Estimate

PROSotera Health Sees FY2026 Adj EPS $0.93-$1.01 vs $0.94 Est; Sees Sales $1.233B-$1.251B vs $1.228B Est

PRO
Sotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M Estimate

PRO
Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B Est

PRO
Sotera Health Affirms FY2026 Adj EPS Guidance of $0.93-$1.01 vs $0.96 Est; Affirms FY2026 Sales Guidance of $1.233B-$1.251B vs $1.239B Est

PRO
Sotera Health Q1 Adj. EPS $0.18 Beats $0.17 Estimate, Sales $280.045M Beat $270.774M Estimate

PRO
Sotera Health Sees FY2026 Adj EPS $0.93-$1.01 vs $0.94 Est; Sees Sales $1.233B-$1.251B vs $1.228B Est